Concord Drugs Limited (CONCORD.BO)
INR 36.45
(-2.72%)
INR 36.45
(-2.72%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 449.24 Million INR | -13.74% |
| 2022 | 520.8 Million INR | -11.66% |
| 2021 | 589.56 Million INR | 14.8% |
| 2020 | 513.57 Million INR | 0.04% |
| 2019 | 513.38 Million INR | 6.62% |
| 2018 | 481.53 Million INR | -7.25% |
| 2017 | 519.17 Million INR | -9.92% |
| 2016 | 576.35 Million INR | 13.27% |
| 2015 | 508.84 Million INR | 25.97% |
| 2014 | 403.93 Million INR | 18.54% |
| 2013 | 340.74 Million INR | 21.4% |
| 2012 | 280.67 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 116.92 Million INR | -25.25% |
| 2023 FY | 449.24 Million INR | -13.74% |
| 2023 Q4 | 156.42 Million INR | 22.36% |
| 2023 Q3 | 127.83 Million INR | 70.07% |
| 2023 Q2 | 75.16 Million INR | -16.31% |
| 2023 Q1 | 89.81 Million INR | -27.02% |
| 2022 Q4 | 123.06 Million INR | -9.02% |
| 2022 FY | 520.8 Million INR | -11.66% |
| 2022 Q3 | 135.27 Million INR | -1.37% |
| 2022 Q2 | 137.15 Million INR | 9.45% |
| 2022 Q1 | 125.31 Million INR | -18.97% |
| 2021 Q1 | 202.19 Million INR | 142.26% |
| 2021 Q2 | 98.3 Million INR | -51.38% |
| 2021 Q4 | 154.64 Million INR | 15.05% |
| 2021 Q3 | 134.41 Million INR | 36.73% |
| 2021 FY | 589.56 Million INR | 14.8% |
| 2020 Q4 | 83.46 Million INR | 1.28% |
| 2020 FY | 513.57 Million INR | 0.04% |
| 2020 Q3 | 82.4 Million INR | -50.26% |
| 2020 Q1 | 182.03 Million INR | 39.72% |
| 2020 Q2 | 165.66 Million INR | -8.99% |
| 2019 FY | 513.38 Million INR | 6.62% |
| 2019 Q2 | 140.94 Million INR | 5.89% |
| 2019 Q4 | 130.28 Million INR | 19.46% |
| 2019 Q3 | 109.05 Million INR | -22.62% |
| 2019 Q1 | 133.1 Million INR | -7.21% |
| 2018 Q2 | 114.91 Million INR | -11.82% |
| 2018 FY | 481.53 Million INR | -7.25% |
| 2018 Q4 | 143.44 Million INR | 55.75% |
| 2018 Q1 | 130.31 Million INR | -38.22% |
| 2018 Q3 | 92.1 Million INR | -19.85% |
| 2017 Q1 | 209.73 Million INR | -2.13% |
| 2017 FY | 519.17 Million INR | -9.92% |
| 2017 Q4 | 210.95 Million INR | 253.88% |
| 2017 Q3 | 59.61 Million INR | 58.24% |
| 2017 Q2 | 37.67 Million INR | -82.04% |
| 2016 Q1 | 129.54 Million INR | -7.22% |
| 2016 FY | 576.35 Million INR | 13.27% |
| 2016 Q3 | 92.14 Million INR | -33.66% |
| 2016 Q4 | 214.3 Million INR | 132.58% |
| 2016 Q2 | 138.89 Million INR | 7.22% |
| 2015 Q4 | 139.62 Million INR | 5.26% |
| 2015 Q2 | 118.88 Million INR | 2.79% |
| 2015 Q1 | 115.65 Million INR | 979.29% |
| 2015 FY | 508.84 Million INR | 25.97% |
| 2015 Q3 | 132.65 Million INR | 11.58% |
| 2014 Q1 | 95.02 Million INR | 1.25% |
| 2014 FY | 403.93 Million INR | 18.54% |
| 2014 Q4 | 10.71 Million INR | -89.37% |
| 2014 Q3 | 100.82 Million INR | 3.7% |
| 2014 Q2 | 97.22 Million INR | 2.32% |
| 2013 Q3 | 88.12 Million INR | 8.09% |
| 2013 Q2 | 81.53 Million INR | 7.26% |
| 2013 Q4 | 93.85 Million INR | 6.5% |
| 2013 FY | 340.74 Million INR | 21.4% |
| 2013 Q1 | 76.01 Million INR | 6.9% |
| 2012 FY | 280.67 Million INR | 0.0% |
| 2012 Q4 | 71.1 Million INR | 0.97% |
| 2012 Q3 | 70.42 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -4182.792% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 57.164% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -12.247% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -21.357% |
| Sunil Healthcare Limited | 901.91 Million INR | 50.19% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -2343.94% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.201% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -0.707% |
| Patidar Buildcon Limited | 2.3 Million INR | -19364.688% |
| Roopa Industries Limited | 715.53 Million INR | 37.216% |
| Smruthi Organics Limited | 1.27 Billion INR | 64.805% |
| Trident Lifeline Limited | 446.28 Million INR | -0.663% |
| PANJON LTD. | 125.52 Million INR | -257.904% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -197.275% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 6.358% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 93.057% |
| Crestchem Limited | 212.56 Million INR | -111.348% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -7991.589% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 33.228% |
| Tyche Industries Limited | 696.83 Million INR | 35.531% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 87.096% |
| Trimurthi Limited | 42.23 Million INR | -963.604% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 39.758% |
| Norris Medicines Limited | 56.35 Million INR | -697.154% |
| Zenlabs Ethica Limited | 585.63 Million INR | 23.289% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 64.178% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 69.253% |
| Parmax Pharma Limited | 154.24 Million INR | -191.257% |
| Veerhealth Care Limited | 142.13 Million INR | -216.071% |
| Deccan Health Care Limited | 597.28 Million INR | 24.786% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 90.308% |
| Makers Laboratories Limited | 1.03 Billion INR | 56.705% |
| Lactose (India) Limited | 1.13 Billion INR | 60.554% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -13.325% |
| Zenith Healthcare Limited | 144.71 Million INR | -210.43% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 16.322% |
| Bacil Pharma Limited | - INR | -Infinity% |
| PRAVEG LIMITED | 915.96 Million INR | 50.954% |
| Denis Chem Lab Limited | 1.67 Billion INR | 73.231% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 85.375% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 68.356% |
| Colinz Laboratories Limited | 70.29 Million INR | -539.076% |
| Godavari Drugs Limited | 1.56 Billion INR | 71.333% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -40082.916% |
| Zenotech Laboratories Limited | 368.08 Million INR | -22.048% |
| Panchsheel Organics Limited | 1.05 Billion INR | 57.304% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 64.316% |
| Vivanza Biosciences Limited | 278.89 Million INR | -61.082% |
| Phaarmasia Limited | 305.93 Million INR | -46.844% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 96.687% |
| Medi-Caps Limited | 265.63 Million INR | -69.121% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -23.843% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 73.546% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 74.23% |
| Mercury Laboratories Limited | 755.59 Million INR | 40.544% |
| Gennex Laboratories Limited | 867.14 Million INR | 48.193% |
| BDH Industries Limited | 858.31 Million INR | 47.659% |
| Coral Laboratories Limited | 836.6 Million INR | 46.301% |
| Bharat Parenterals Limited | 2.59 Billion INR | 82.682% |
| Beryl Drugs Limited | 271.24 Million INR | -65.622% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -336.677% |
| Evoq Remedies Limited | 63.09 Million INR | -612.07% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 77.769% |
| Transchem Limited | 4.09 Million INR | -10857.198% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -195.797% |
| Parnax Lab Limited | 1.88 Billion INR | 76.194% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -64.578% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 56.101% |
| Cian Healthcare Limited | 616.95 Million INR | 27.184% |
| Trinity League India Limited | 2.95 Million INR | -15128.644% |
| Syschem (India) Limited | 2.33 Billion INR | 80.763% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 71.095% |
| Auro Laboratories Limited | 526.99 Million INR | 14.754% |